Dr. Fox focuses on translating early-stage pharmaceutical technologies into development candidates with commercial potential. Currently, they serve as Director at JMCA Research Ltd and hold non-executive chair positions at Ferryx and SignaCor. Dr. Fox has over 30 years of experience in drug development, having previously worked as Chief Development Officer and Chief Executive Officer at Merrion Pharmaceuticals plc. They have held various senior roles at Shire Pharmaceuticals, and co-founded Hunter Fleming, successfully taking compounds to clinical trials. Dr. Fox obtained a PhD in Biochemistry from Queen's University Belfast and an MBA from Henley Management College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices